Parker Waichman LLP

Cerebellar Atrophy Reported in Dilantin Patients

The U.S. Food and Drug Administration (FDA) has approved labeling changes stating that cerebellar atrophy has been reported in patients taking phenytoin. This nervous system adverse reaction appears to occur more frequently when drug levels are elevated or when it is used long-term. Phenytoin is sold by Pfizer under the brand name Dilantin; it is […]

The U.S. Food and Drug Administration (FDA) has approved labeling changes stating that cerebellar atrophy has been reported in patients taking phenytoin. This nervous system adverse reaction appears to occur more frequently when drug levels are elevated or when it is used long-term. Phenytoin is sold by Pfizer under the brand name Dilantin; it is used to treat patients with epilepsy.

According to the FDA, cases of cerebellar atrophy, or degeneration of the cerebellum, have been reported in patients taking Dilantin. The cerebellum is an area of the brain that controls movement, balance and coordination. Impairment to the cerebellum can cause an unsteady gait, poor muscle control, trouble speaking or swallowing and other movement related problems.

Cerebellar atrophy can lead to ataxia, or the loss of voluntary muscle control. Patients with ataxia may have difficulty walking, balancing or running. It can also affect fine motor coordination skills, such as preparing food.

Patients with cerebellar atrophy may also experience changes in their cognition and mood. There have been reports of problems with executive functioning, which is the type of thinking needed to make plans and attain goals. Irritability, anxiety and depression have also been reported.

In the past, researchers thought that cerebellar atrophy was mainly the result of epilepsy itself. However, there have been some studies suggesting that the long-term use of Dilantin may play a role.
A study published in 2002 used magnetic resonance imaging (MRI) to study the brains of 56 epilepsy patients who took phenytoin, the generic name for Dilantin. Over 35 percent of these patients had cerebellar atrophy. Upon statistical analysis, the only factor significantly associated with cerebellar atrophy was the length of time the patient had been taking Dilantin. The authors concluded that while cerebellar atrophy may still be an effect of epilepsy, that factor may be less significant than the length of exposure to phenytoin.

A case study published in 2000 detailed a toddler who took Dilantin and later developed cerebellar atrophy. He began to show signs, including an unsteady gait and difficulty with speech, one year after starting treatment. Physicians found that the levels of Dilantin in his blood were higher than suitable for treatment, which was attributed to the fact that his mother gave him pills she cut in half with a knife. His symptoms persisted months later, despite being taken off the medication.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
They got right on my case. Wasted no time and fought/won the decision to continue with my therapy after the insurance company wanted to terminate it. Even the insurance company knew from my medical records that I needed to continue. My nurse Ms. Joanne Stevens is very concerned about my condition and treatment and assured that I would continue. I am very familiar with this law firm. They are like human pitbulls when they latch onto a wrong door. Humph!!! I'm glad they're on my side.
JANICE Peters-Rowe
5 years ago
5 Star Reviews 150
They got the job done!
Stephanie Fede
4 years ago
5 Star Reviews 150
Parker Waichman LLP were very compassionate with my case. Michele Josama was absolutely wonderful. She keep me very informed throughout the process. She was thorough and knowledgeable. Michele Josama is truly an asset to this firm.
Yesenia Bonilla
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038